Stocks
Kura Oncology, Inc.KURA
NASDAQHealthcareBiotechnology$8.65-2.15%
Focused on precision medicine, the company develops targeted therapies for cancer treatment, leveraging advancements in molecular biology and genetics. Its pipeline includes investigational drugs aimed at addressing unmet medical needs in oncology, making it a key player in the biotech space. Investors monitor its progress due to its potential to disrupt traditional cancer therapies and deliver significant returns.
Market Cap: $764.1M52W Range: $5.41 – $12.49
Congressional Interest in Kura Oncology, Inc. (KURA)
1 member of Congress has disclosed 1 trade in Kura Oncology, Inc. (KURA), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading KURA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-12 | Christopher L. Jacobs | buy | $1K – $15K |